Regenicin, Inc. (OTCPK: RGIN)
Health Care · Biotechnology · US
$0.00
— today · -99.0% 1Y
Regenicin, Inc. (OTCPK: RGIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $153.00 and employs 3 people.
Over the last twelve months the share price has lost 99.0%, trading between 0.00 and 0.75.
Tweenvest scores Regenicin, Inc. across four factors: quality 35/100, value 46/100. Its strongest factor is value.
RGIN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $153.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 33.29
- 52-week high
- $0.75
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 153.48M
- Employees
- 3
- Next earnings
- —
About Regenicin, Inc.
Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
- ISIN
- US75887Q1022
- Founded
- 2007
- Listed since
- Nov 16, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tengion, Inc.OTCPK: TNGN.Q | $402.00 | $— | — |
| NanoLogix, Inc.OTCPK: NNLX | $326.00 | $— | — |
| Predictive Technology Group, Inc.OTCPK: PRED.Q | $317.00 | $0.00 | -99.90% |
| Sirona Biochem Corp.OTCPK: SRBC.F | $266.00 | $— | — |
| Immage Biotherapeutics Corp.OTCPK: IMMG | $152.00 | $— | — |
| Poniard Pharmaceuticals, Inc.OTCPK: PARD | $150.00 | $— | — |
| CardioGenics Holdings IncOTCPK: CGNH | $143.00 | $— | — |
| NexImmune, Inc.OTCPK: NEXI | $139.00 | $— | — |
Figures last refreshed Oct 4, 2026.